The largest database of trusted experimental protocols

Halt phosphatase inhibitor

Manufactured by Thermo Fisher Scientific
Sourced in United States, Switzerland

Halt phosphatase inhibitor is a laboratory reagent designed to inhibit the activity of phosphatases, enzymes that remove phosphate groups from molecules. It is commonly used in biochemical and cell biology research to preserve the phosphorylation state of proteins during sample preparation and analysis.

Automatically generated - may contain errors

97 protocols using halt phosphatase inhibitor

1

Cytoplasmic and Nuclear Fractionation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cytoplasmic and nuclear fractionation, AML12 cells were grown to 100% confluency, washed twice with ice-cold PBS and incubated with buffer A (10 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, pH 7.9, PMSF 50 µg ml−1, Na-Orthovanadate 1 mM, DTT 1 mM, NP-40 (0.6%), HALT-Phosphatase inhibitor (Thermoscientific) 1:1000, complete Protease-inhibitor tablet (Thermoscientific)) on ice for 15 min. Cells were collected and centrifuged for 5 min at 14,000 × g. Supernatant (cytoplasmic fraction) was collected and saved. The pellet was processed further for nuclear extraction by washing with buffer A without NP-40, followed by resuspension in buffer C (10 mM HEPES, 0.4 mM NaCl, 1 mM EDTA, 1 mM EGTA, pH 7.9, PMSF 50 µg ml−1, Na-Orthovanadate 1 mM, DTT 1 mM, NP-40 (0.6%), HALT-Phosphatase inhibitor (Thermoscientific) 1:1000, complete Protease-inhibitor tablet (Thermoscientific)) and incubation on ice for 15 min, vortexing every minute. Fraction was centrifuged at 14,000 × g for 8 min and supernatant (nuclear fraction) collected.
+ Open protocol
+ Expand
2

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in RIPA buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, protease inhibitor cocktail (Roche, Indianapolis, IN, USA) and Halt™ phosphatase inhibitor (Thermo Fisher Scientific). The lysates were incubated on ice for 20 min and collected by centrifugation at 13,000 rpm for 20 min at 4°C. The supernatants were removed to clean tubes, mixed with 5× sample buffer, and heated at 100°C for 5 min. Proteins were separated by SDS-PAGE through 10% gels and transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA, USA). Membranes were blocked in phosphate-buffered saline (PBS) containing 5% (w/v) bovine serum albumin (BSA, Bioworld, Dublin, OH, USA) and 0.05% (v/v) Tween 20 (PBST) for 1 h and incubated overnight at 4°C with primary antibody against STAT3 or phospho-STAT3 (Cell Signaling Technology, Danvers, MA, USA). Antibody against GAPDH (sc-25778, Santa Cruz Biotechnology) was used as internal control. Membranes were incubated with horseradish peroxidase (HRP)-labeled secondary antibodies (SC-2005, Santa Cruz Biotechnology) for 1 h and visualized using Immobilon Western Chemiluminescent HRP Substrate (Millipore).
+ Open protocol
+ Expand
3

Glioblastoma Tissue Protein Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
GBM primary tumor samples were homogenized and powdered in liquid nitrogen using a mixer mill (Retsch Inc., Haan, Germany). Samples were maintained at liquid N2 temperature throughout the process. Homogenized and powdered tissue samples were then re-suspended in 5X volume of the weight of the tissue sample in a reducing buffer (125 mM Tris pH 6.8, 4% SDS (w/v), 10% glycerol (v/v), 5% 2-mercaptoethanol (v/v), complete protease inhibitor (Roche Diagnostics Corp., Indianapolis, IN, USA), HALT phosphatase inhibitor (Thermo Fisher Scientific, Grand Island, NY, USA). Samples were then heated to 70°C with mixing at 1,400 rpm for 10 min, sonicated with a tip sonicator for 30 sec at power level 4, and then centrifuged at 16,000 × g for 10 min at room temperature. The supernatant was then collected.
+ Open protocol
+ Expand
4

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flash-frozen tumors were homogenized in PBS with Halt phosphatase inhibitor (Thermo Fisher Scientific) and protease inhibitor (Sigma-Aldrich) using the Precellys Evolution Homogenizer with Cryolys (Bertin Instruments). The preset elastic setting was used for homogenizing. Tumor homogenates were centrifuged to remove PBS and resuspended in RIPA buffer with phosphatase and protease inhibitors. Lysates were sonicated 2 × 10 s using a Branson digital sonifier at 10% amplitude. Samples were centrifuged at 15,000 rpm for 5 min at 4°C and supernatants collected and quantified by Bradford assay (Bio-Rad). Samples (35 μg total) were blotted for BRAF (sc-5284; 1:500; Santa Cruz) and β-Actin (#3700; 1:1,000; Cell Signaling) and imaged using a LI-COR Odyssey CLx system. Bands were quantified using Image Studio Version 5.2 software (LI-COR Biosciences).
+ Open protocol
+ Expand
5

Detergent-Based Brain Protein Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brain homogenates [10% (w/v)] were prepared in PBS using a Minilys homogenizer and CK14 homogenizing tubes. Nine volumes of brain homogenate were then mixed with one volume of 10X detergent buffer [5% (v/v) Nonidet P-40, 5% (w/v) sodium deoxycholate in PBS] containing Pierce Universal Nuclease (ThermoFisher #88701) and Halt Phosphatase Inhibitor (ThermoFisher #78420), and then incubated on ice for 20 min. Samples were clarified by centrifugation at 1000x g for 5 min at 4 °C to generate detergent-extracted brain homogenate. For thermolysin (SigmaAldrich #T7902) digestions, extracts were treated with 50 μg/mL protease (TL:protein ratio of 1:100) at 37 °C for 1 h with constant agitation (600 rpm). Digestions were terminated by the addition of ethylenediaminetetraacetic acid (EDTA) to a final concentration of 5 mM. For PK digestions, detergent-extracted brain homogenates were treated with 100 μg/mL PK (PK:protein ratio of 1:50) at 37 °C for 1 h with constant agitation (600 rpm). Digestions were terminated by the addition of PMSF to a final concentration of 4 mM. Following digestion, samples were ultracentrifuged at 100,000x g for 1 h at 4 °C. The supernatant was discarded, and the pellets were resuspended by boiling in loading buffer. Samples were then analyzed by SDS-PAGE followed by immunoblotting.
+ Open protocol
+ Expand
6

Western Blot Analysis of Cerebellar and B-Cell Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse cerebellar tissues and B-lymphocyte cell pellets were homogenized with a cell lysis buffer (Cell Signaling) with Halt phosphatase inhibitor (Thermo-Fisher), complete protease inhibitors (Roche) and PSMF (Sigma-Aldrich). Thirty micrograms of lysates were loaded into 4–12% Bis–Tris gels (Invitrogen). Electrophoresis was carried out according to the manufacturer's recommendations. Following electrophoresis, the proteins were transferred to nitrocellulose membranes by the iBlot device (Invitrogen), blocked with an Odyssey blocking buffer (LI-COR Biotechnology) for 1 h. Membranes were incubated overnight with the following primary antibodies in blocking buffer: COX1 (ab133319 for human, ab133319 for mouse; Abcam), COX2 (ab62331 for human, ab6665 for mouse; Abcam), phospho-CREB (4095), phospho-cJun/AP1 (5464), phospho-NFκB (4025; Cell signaling), cPLA2 (sc-454), phospho-cPLA2 (sc-34391; Santa Cruz Biotech, Santa Cruz, CA, USA), β-actin (A5441; Sigma-Aldrich), and β-tubulin (DSHB-E7; DSHB, Iowa). Subsequently, the membranes were incubated with a corresponding pair of IRDye 680CW and IRDye 800CW-coupled secondary antibodies (LI-COR). Proteins were visualized with the Odyssey infrared imager and software (LI-COR) according the manufacturer's instruction.
+ Open protocol
+ Expand
7

Protein Extraction and Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
500,000 cells/ml were seeded and incubated as mentioned. Cells were pelleted and washed once with ice-cold PBS. Proteins were extracted using RIPA (50 mmol/L Tris-HCL pH 8.0, 150 mmol/L NaCl, 1% NP40, 0.5% sodium deoxycholate, and 0.1% SDS), 7 x protease inhibitor (Thermo Scientific 1862209), Halt phosphatase inhibitor (Thermo Scientific 1862495) and Triton X-100. Proteins were extracted and quantified using BCA assay (Thermo 23208). 30 ug of proteins was loaded in each well for western blotting and developed using autoradiography films (VWR 30101) after incubation with antibodies. Primary antibodies were all used at a concentration of 1:1000 and secondary antibodies were used at a concentration of 1:10,000.
+ Open protocol
+ Expand
8

Western Blotting for CLIP Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
To check the expression of CLIP proteins, cells were directly lysed into appropriate volumes of 1×SDS-PAGE sample buffer. Unless noted, 7.5% Tris-glycine gels were used. For Western blotting, all proteins were transferred to Immobilon® - FL (Millipore, Billerica, MA) membranes to scan and quantify with Odyssey Classic infrared imaging system (LICOR, Lincoln, NE). Non-specific binding was blocked with Tris-HCl buffer (pH 8.0) containing 3% skim milk.
For western blots on patient samples, 5–10 mg of frozen tumor tissue was suspended in 100 μl of RIPA buffer containing cOmplete EDTA-free protease inhibitors (Roche, Basel, Switzerland) and Halt phosphatase inhibitor (Thermo Fisher Scientific, Waltham, MA), homogenized using a hand-held homogenizer; 80 μg of total cell protein from each sample was resolved by SDS-PAGE and immunoblotted as indicated.
+ Open protocol
+ Expand
9

Western Blot Analysis of Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were analyzed by western blotting as described previously.25 (link),55 (link) Cells were washed with ice-cold PBS, and total protein extract was prepared with RIPA buffer with 1× Halt protease inhibitor cocktail and Halt phosphatase inhibitor (Thermo Fisher Scientific) at a ratio of 5 × 106 cells/mL. 30 μg protein for iPSC-derived OCs or 15 μg for iPSC-LESCs was loaded onto 4%–15% Mini-PROTEAN TGX gels (Bio-Rad, CA, USA) and transferred to an Immun-Blot polyvinylidene fluoride (PVDF) membrane using a Trans-Blot SD semi-dry transfer cell (Bio-Rad). Membranes were blocked with 5% non-fat dry milk in PBS-Tween 20 (0.1%) for 2 h and incubated overnight at 4°C with the following primary antibodies diluted in blocking buffer: PAX6 (1:2,000, Covance), ABCG2 (1:1,000, Santa Cruz Biotechnology), and β-actin (1:5,000, Sigma-Aldrich). Incubation with horseradish peroxidase-conjugated secondary antibody (anti-mouse or -rabbit, 1:5,000, Applied Biosystems) was done for 2 h at room temperature. Membranes were incubated with Clarity Western ECL Substrate (Bio-Rad) and imaged using the ChemiDoc XRS Imaging System (Bio-Rad). Band intensities were quantified using the Fiji/ImageJ software (National Institutes of Health, MD, USA).
+ Open protocol
+ Expand
10

Western Blot Analysis of Akt and pAkt

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed with RIPA buffer (Sigma–Aldrich, Taufkirchen, Germany) containing Complete™ protease inhibitor cocktail (Thermo Fisher Scientific, Dreieich, Germany), HALT™ protease inhibitor and HALT™ phosphatase inhibitor (Thermo Fisher Scientific, Dreieich, Germany). Western blot was performed with proteins from whole cell lysates. Primary antibodies: anti-Akt and anti-pAkt (Ser473) (Cell Signaling, Frankfurt a. M., Germany); anti-β-actin (Abcam, Cambridge, UK). Secondary antibodies: goat anti-rabbit and goat anti-mouse (Santa Cruz, Heidelberg, Germany). For detection, Western blotting Luminol Reagent (Santa Cruz, Heidelberg, Germany), and Amersham Hyperfilm™ ECL (GE Healthcare Limited, Buckinghamshire, UK) were used. Densitometry was done using ImageJ 1.48v (Wayne Rasband (National Institutes of Health), MD, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!